研究发现,荷尔蒙替代疗法对乳腺癌风险的影响因类型而异。 Study finds hormone replacement therapy impacts breast cancer risk differently, depending on type.

最近对年龄在16至54岁之间的459 476名妇女进行的一项研究发现,更年期前某些类型的激素替代疗法(HRT)可能会影响乳腺癌风险。 A recent study on 459,476 women aged 16 to 54 found that certain types of hormone replacement therapy (HRT) before menopause can affect breast cancer risk. 雌激素治疗将风险降低14%,同时与蛋白质结合将风险增加10%。 While estrogen therapy decreased risk by 14%, combining it with progestin increased risk by 10%. 这项研究强调了患者与医疗保健提供者之间关于HRT的好处和风险的个性化讨论的必要性, This research highlights the need for personalized discussions between patients and healthcare providers about HRT benefits and risks, especially for younger women.